The ADCK5 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from human embryonic kidney 293T cells, in which the ADCK5 gene has been disrupted to create a loss-of-function model. This product is designed for investigating the mitochondrial atypical kinase ADCK5, which plays a critical role in coenzyme Q biosynthesis and oxidative phosphorylation. As a polyclonal pool, it provides an averaged representation of ADCK5 ablation effects, avoiding clonal selection bias while maintaining experimental consistency.
HEK293T cells are a widely used human cell line immortalized by the SV40 large T antigen, enabling high-level episomal replication and exceptional transfectability. These features make them a standard host for recombinant protein expression and lentiviral packaging. In the context of this knockout model, the HEK293T background ensures efficient delivery of editing components and a well-characterized system for studying mitochondrial biology.
The ADCK5 protein localizes to the inner mitochondrial membrane where it phosphorylates components of the coenzyme Q biosynthesis machinery, including COQ3, COQ5, and COQ7, to promote CoQ10 (ubiquinone) production. ADCK5 is regulated upstream by AMPK and PGC-1?? and functions downstream of NRF1 and TFAM, with its activity essential for mitochondrial complex I stability. Loss of ADCK5 function disrupts electron transport, reducing ATP synthesis and increasing mitochondrial ROS. ADCK5 also interacts with COQ9, cardiolipin, and related atypical kinases ADCK3 and ADCK4, positioning it within a network that coordinates mitochondrial bioenergetics and quality control.
In HEK293T cells, ADCK5 knockout offers a flexible platform to study the molecular consequences of CoQ10 deficiency, as these cells retain full oxidative phosphorylation capacity despite their glycolytic preference. The polyclonal nature allows robust evaluation of mitochondrial respiration defects via Seahorse analysis and ATP assays, while also supporting drug screening for compounds that rescue CoQ10 levels. Additionally, the model can be used for lentiviral rescue and packaging studies, leveraging the host line’s inherent capabilities.
Researchers can use these cells to model mitochondrial disorders linked to CoQ10 deficiency, such as mitochondrial encephalopathy and nephrotic syndrome, employing techniques like RT-qPCR for mitochondrial gene expression, HPLC for ubiquinone quantification, and immunofluorescence for mitochondrial morphology. The polyclonal knockout pool is also suitable for investigating ADCK5 interactions with COQ5 and COQ7 via co-immunoprecipitation, and for high-throughput screening of therapeutic candidates. For additional technical details or to inquire about custom services, please contact Ascent Research.
